Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,691,029
-
Share change
-
-393,364
-
Total reported value
-
$19,450,577
-
Put/Call ratio
-
79%
-
Price per share
-
$5.27
-
Number of holders
-
29
-
Value change
-
-$2,368,802
-
Number of buys
-
13
-
Number of sells
-
12
Institutional Holders of CYCLACEL PHARMACEUTICALS INC - COM (CYCC) as of Q3 2021
As of 30 Sep 2021,
CYCLACEL PHARMACEUTICALS INC - COM (CYCC) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,691,029 shares.
The largest 10 holders included
Tri Locum Partners LP, SPHERA FUNDS MANAGEMENT LTD., Sio Capital Management, LLC, Affinity Asset Advisors, LLC, SILVERARC CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., TWO SIGMA ADVISERS, LP, MORGAN STANLEY, and CITADEL ADVISORS LLC.
This page lists
29
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.